Recent Progress in Tumor Virology Research
Clinical trials have indicated that oncoviruses might be developed as safe and effective anticancer agents. No​vel strategies can be used to facilitate viral evasion of the immune system, the prevention of viral uptake by the liver, and an increased specificity for tumour cells, either at the cell surface or through intracellular restriction.
- The search for novel tumor viruses
- Understanding human carcinogenesis by using tumor viruses as experimental tools
- Defense against the use of viruses in bioterrorism
Related Conference of Recent Progress in Tumor Virology Research
September 22-23, 2025
11th International Conference on Infectious and Rare Diseases
Vancouver, Canada
October 06-07, 2025
13th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs
Las Vegas, USA
October 30-31, 2025
20th World Conference on Infectious Diseases, Prevention and Control
Paris, France
December 11-12, 2025
8th Annual Congress on Bacterial, Viral and Infectious Diseases
Prague, Czech Republic
December 17-18, 2025
17th Global Conference on Nephrology and Infectious Diseases
Amsterdam, Netherlands
December 22-23, 2025
6th International Conference on Microbiology and Infectious Diseases
Barcelona, Spain
January 20-21, 2026
7th Annual Meeting on Infectious Diseases, Microbiology & Beneficial Microbes
Aix-en-Provence, France
January 22-23, 2026
10th International Conference on Infectious Diseases: Control and Prevention
Aberdeen, UK
May 14-15, 2026
13th International Conference on Infectious Diseases, Bacteriology and Antibiotics
Paris, France
May 18-18, 2026
6th World Congress on Tuberculosis, Lung Infections, and Respiratory Care
Aix-en-Provence, France
Recent Progress in Tumor Virology Research Conference Speakers
Recommended Sessions
- Current Focus in Virology Research
- Development of Antivirals
- Molecular Virology
- Viral Vaccines
- Clinical Virology
- Future of Virology
- Neurovirology
- New and re-emerging viruses
- Plant and Agricultural Virology
- Recent Progress in Tumor Virology Research
- Respiratory Viral Infections
- Viral infections and diseases
- Viral drug resistance
- Viral Oncology
- Viral Vaccines
- Virotherapy
- Viruses and Tumors
Related Journals
Are you interested in
- 1.Infectious Diseases and Neuro Infectious Diseases - Infectious Diseases_2025 (Canada)
- 10. HIV/AIDS - Infectious Diseases_2025 (Canada)
- 11. Pediatric Infectious Diseases/ Childhood Infectious Diseases - Infectious Diseases_2025 (Canada)
- 12. Respiratory Diseases - Infectious Diseases_2025 (Canada)
- 13. Sexually Transmitted Diseases/ Sexually Transmitted Infections - Infectious Diseases_2025 (Canada)
- 14. Viral Infectious Diseases - Infectious Diseases_2025 (Canada)
- 15. Malaria and Hepatitis - Infectious Diseases_2025 (Canada)
- 16. Immunology of Infections - Infectious Diseases_2025 (Canada)
- 17. Vaccines and Vaccination - Infectious Diseases_2025 (Canada)
- 18. Tuberculosis - Infectious Diseases_2025 (Canada)
- 19. New Antiviral, Antibacterial and Antifungal Agents - Infectious Diseases_2025 (Canada)
- 2. Coronavirus(nCOV) - Infectious Diseases_2025 (Canada)
- 20. Nosocomial Infections - Infectious Diseases_2025 (Canada)
- 21. Parasitic Diseases - Infectious Diseases_2025 (Canada)
- 22. Surgical Site Infections - Infectious Diseases_2025 (Canada)
- 3. Infectious Diseases Prevention, Control and Cure - Infectious Diseases_2025 (Canada)
- 4. Bacterial & Fungal Infectious Diseases - Infectious Diseases_2025 (Canada)
- 5. Rare Infectious Diseases and Immune Deficiencies - Infectious Diseases_2025 (Canada)
- 6. Rare Diseases in Cancer and Aging - Infectious Diseases_2025 (Canada)
- 7. Global Trends in Emerging Infectious Diseases - Infectious Diseases_2025 (Canada)
- 8. Ebola and Zika Viral Infections - Infectious Diseases_2025 (Canada)
- 9. Clinical Research and Public Awareness - Infectious Diseases_2025 (Canada)
- A prospective study of dermatological infections - Emerging Infectious Diseases 2025 (Canada)
- Advancements in Vaccines and Therapeutic - Infectious Diseases 2026 (France)
- Alcohol and Drug Use - STD-HIV AIDS-2025 (USA)
- Antigen-Antibody Reactions - Infectious Diseases 2026 (France)
- Antimicrobial Resistance - Emerging Infectious Diseases 2025 (Canada)
- Antimicrobial Resistance (AMR) - Infection Congress 2026 (UK)
- Antimicrobial Stewardship/Antimicrobial Resistance - Infection Prevention 2025 (UK)
- Bacterial Infections and Antimicrobial Resistance (AMR) - Euro Infectious Diseases 2026 (UK)
- Bacterial Infections and Diseases - Infectious Diseases 2026 (France)
- Bacterial Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Bacterial, Parasitic and Fungal Infections - Infection Prevention 2025 (UK)
- Biofertilizers - Infectious Diseases 2026 (France)
- Biomarkers for Rare Disease Diagnosis and Treatment - Rare Diseases Congress 2026 (Czech Republic)
- Biomedical Research - Rare Diseases Congress 2026 (Czech Republic)
- Blood Borne Infections/Sepsis/Septicaemia - Infection Prevention 2025 (UK)
- Cardiovascular Diseases and Disorders - Emerging Infectious Diseases 2025 (Canada)
- Causes and Symptoms of Infections - Infection Prevention 2025 (UK)
- Causes and Symptoms of Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Challenges of Living with a Rare Disease: - Rare Diseases Congress 2026 (Czech Republic)
- Changing Patterns of Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Climate Change and Infectious Diseases - Infection Congress 2026 (UK)
- Climate Change, Urbanization, and Infectious Disease Spread - Euro Infectious Diseases 2026 (UK)
- Clinical and Case Reports - INFECTIOUS DISEASES-2026 (France)
- Clinical Case Reports and Case Studies - Rare Diseases Congress 2026 (Czech Republic)
- Clinical Management of Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Clinical Research and Case Reports - STD-HIV AIDS-2025 (USA)
- Clinical Research on Orphan Drugs - Rare Diseases Congress 2026 (Czech Republic)
- Co-infections Associated with STDs - STD-HIV AIDS-2025 (USA)
- Coronavirus Disease (COVID-19) - INFECTIOUS DISEASES-2026 (France)
- COVID-19 - Infectious Diseases 2026 (France)
- COVID-19 Variants - Infection Congress 2026 (UK)
- Covid_19 Infections - Infection Prevention 2025 (UK)
- Dental diseases & Infections - Emerging Infectious Diseases 2025 (Canada)
- Diabetes and Wound Care - Emerging Infectious Diseases 2025 (Canada)
- Diagnosis and Treatment - STD-HIV AIDS-2025 (USA)
- Diagnosis of infectious Diseases - Infection Prevention 2025 (UK)
- Diagnostics and Laboratory Techniques - Emerging Infectious Diseases 2025 (Canada)
- Diagnostics and Molecular Tools in Infectious Disease - Euro Infectious Diseases 2026 (UK)
- Different Types of Rare Diseases: - Rare Diseases Congress 2026 (Czech Republic)
- Drug Discovery for Rare Diseases: - Rare Diseases Congress 2026 (Czech Republic)
- Emerging and Re-Emerging Infections - Infection Prevention 2025 (UK)
- Emerging Infectious Diseases - Infection Congress 2026 (UK)
- Emerging Technologies in Rare Disease Research - Rare Diseases Congress 2026 (Czech Republic)
- Epidemiology - Infection Prevention 2025 (UK)
- Epidemiology - INFECTIOUS DISEASES-2026 (France)
- Epidemiology and Public Health - Infection Congress 2026 (UK)
- Epidemiology and Surveillance - Emerging Infectious Diseases 2025 (Canada)
- Fungal Infections - Infectious Diseases 2026 (France)
- Fungal Infections: Diagnosis and Emerging Threats - Euro Infectious Diseases 2026 (UK)
- Fungal Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Gastrointestinal and Urinary Tract Infections - Infection Prevention 2025 (UK)
- Gene Expression - Infectious Diseases 2026 (France)
- Global Climatic Change and Emerging Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Global Health Security - Emerging Infectious Diseases 2025 (Canada)
- Global Health Security - Infection Congress 2026 (UK)
- Global hotspots and correlates of emerging zoonotic diseases - Emerging Infectious Diseases 2025 (Canada)
- Global Trends in Emerging Infections - Infection Prevention 2025 (UK)
- Health Economics and Market Access for Orphan Drugs - Rare Diseases Congress 2026 (Czech Republic)
- Hepatitis Prevention - Infection Prevention 2025 (UK)
- HIV and Women's Health Issues - STD-HIV AIDS-2025 (USA)
- HIV/AIDS and Sexually Transmitted Infections (STIs) - Euro Infectious Diseases 2026 (UK)
- Hospital-Acquired Infections (Nosocomial Infections) - Infection Congress 2026 (UK)
- Human Monkeypox: An Emerging Zoonosis - Emerging Infectious Diseases 2025 (Canada)
- Immunizations and Vaccination - Infection Prevention 2025 (UK)
- Infection Control and Hospital-Acquired Infections (HAIs) - Euro Infectious Diseases 2026 (UK)
- Infection Control in Critical Care - Infection Prevention 2025 (UK)
- Infection Control Procedures - Infection Prevention 2025 (UK)
- Infection Prevention and Control - Infection Prevention 2025 (UK)
- Infection Prevention and Control (IPC) - Infection Congress 2026 (UK)
- Infection, Immunity and Inflammation - INFECTIOUS DISEASES-2026 (France)
- Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Infectious Diseases and Cancer - Infectious Diseases 2026 (France)
- Infectious Diseases and Immune Deficiencies - Rare Diseases Congress 2026 (Czech Republic)
- Infectious Diseases Epidemiology - INFECTIOUS DISEASES-2026 (France)
- Infectious Diseases Prevention, Control and Cure - INFECTIOUS DISEASES-2026 (France)
- Internal Medicine for Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Introduction and Causes of New Rare Diseases: - Rare Diseases Congress 2026 (Czech Republic)
- Mutations - Infectious Diseases 2026 (France)
- Neuro Infections - Infection Prevention 2025 (UK)
- Neuro Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Nosocomial Infections & Control - INFECTIOUS DISEASES-2026 (France)
- Nosocomial Infections and Control - Infection Prevention 2025 (UK)
- Nosocomial Infections and Their Control Strategies - Emerging Infectious Diseases 2025 (Canada)
- One Health and Emerging Global Threats - Euro Infectious Diseases 2026 (UK)
- One Health Approach - Infection Congress 2026 (UK)
- Orphan Drugs Potentiality - Rare Diseases Congress 2026 (Czech Republic)
- Outbreak Investigation and Response - Emerging Infectious Diseases 2025 (Canada)
- Pandemic Preparedness - Infection Congress 2026 (UK)
- Parasitic Infections - Infectious Diseases 2026 (France)
- Parasitic Infections and Neglected Tropical Diseases (NTDs) - Euro Infectious Diseases 2026 (UK)
- Parasitology & Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Pediatric HIV - STD-HIV AIDS-2025 (USA)
- Pediatric Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Pediatric Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Pediatric Infectious Diseases and Immunization Programs - Euro Infectious Diseases 2026 (UK)
- Perspectives on Gastrointestinal Infections - Emerging Infectious Diseases 2025 (Canada)
- Pharmacology of Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Plants Diseases and Infection Control - Infection Prevention 2025 (UK)
- Prion Diseases - Infectious Diseases 2026 (France)
- Probiotics and Prebiotics - Infectious Diseases 2026 (France)
- Probiotics and Prebiotics - Infectious Diseases 2026 (France)
- Public Health - STD-HIV AIDS-2025 (USA)
- Public Health Policy and Preparedness - Emerging Infectious Diseases 2025 (Canada)
- Rapid Diagnostic Technologies - Infection Congress 2026 (UK)
- Rare Autoimmune Disorders: - Rare Diseases Congress 2026 (Czech Republic)
- Rare Bone Diseases - Rare Diseases Congress 2026 (Czech Republic)
- Rare Cancer - Rare Diseases Congress 2026 (Czech Republic)
- Rare Diseases and Orphan Drugs: - Rare Diseases Congress 2026 (Czech Republic)
- Rare Nutritional and Metabolic Diseases - Rare Diseases Congress 2026 (Czech Republic)
- Rare Skin Diseases - Rare Diseases Congress 2026 (Czech Republic)
- Recent Advancements - STD-HIV AIDS-2025 (USA)
- Research on Medicine and Vaccine for Covid-19 - INFECTIOUS DISEASES-2026 (France)
- Respiratory Infectious Diseases and Therapy - Infection Prevention 2025 (UK)
- Respiratory Tract Infections: Viral and Bacterial Perspectives - Euro Infectious Diseases 2026 (UK)
- SARS and MERS: Recent Insights into Emerging Coronaviruses - Emerging Infectious Diseases 2025 (Canada)
- Sepsis and Critical Infections in Clinical Practice - Euro Infectious Diseases 2026 (UK)
- Sexual Health - STD-HIV AIDS-2025 (USA)
- Sexually Transmitted Diseases - STD-HIV AIDS-2025 (USA)
- Sexually Transmitted Diseases (STDs) and Infections (STIs) - Infectious Diseases 2026 (France)
- Testing and Health Monitoring - STD-HIV AIDS-2025 (USA)
- The Science of SARS-CoV-2 - Emerging Infectious Diseases 2025 (Canada)
- Therapeutics and Treatment Strategies - Emerging Infectious Diseases 2025 (Canada)
- Transmission and Prevention - STD-HIV AIDS-2025 (USA)
- Tropical Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Tuberculosis and Mycobacterial Diseases - Euro Infectious Diseases 2026 (UK)
- Vaccine Development - Infection Congress 2026 (UK)
- Vaccine Research and Development - Euro Infectious Diseases 2026 (UK)
- Vaccines and Immunization - Emerging Infectious Diseases 2025 (Canada)
- Vaccines and People with HIV - STD-HIV AIDS-2025 (USA)
- Vaccines and Vaccination - INFECTIOUS DISEASES-2026 (France)
- Vaccines and Vaccination for Rare Diseases: - Rare Diseases Congress 2026 (Czech Republic)
- Vector-Borne Diseases - Infection Congress 2026 (UK)
- Vector-borne diseases: New Approaches to Control Vector from disease transmission - Emerging Infectious Diseases 2025 (Canada)
- Veterinary Diseases - INFECTIOUS DISEASES-2026 (France)
- Veterinary Infectious Diseases - Infectious Diseases 2026 (France)
- Viral Infections and Diseases - Infectious Diseases 2026 (France)
- Viral Infections and Outbreaks - Infection Congress 2026 (UK)
- Viral Infections and Recent Advancements - Infection Prevention 2025 (UK)
- Viral Infections: Trends, Variants, and Global Impact - Euro Infectious Diseases 2026 (UK)
- Viral Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Zoonotic and Vector-Borne Diseases - Euro Infectious Diseases 2026 (UK)
- Zoonotic Diseases - Infection Congress 2026 (UK)